Robert Wenz, MD
Retina Specialist · Canton, OHNPI 1639172984
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 25.9% of the total. Reporting peaked in 2024 at $598 and has fallen 58.7% since, to $247 in 2025. That places this record below the midpoint for retina specialist clinicians in OH, where the typical reported total is $4,390.
Across 109 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$572
- Alimera Sciences, Inc.$343
- Apellis Pharmaceuticals, Inc.$262
- Astellas Pharma US Inc$229
- AbbVie$218
- Genentech USA, Inc.$209
- plus $377 from 10 others
What the payments were for
- Food & beverage$2,19099%
- Gifts$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 25 | $572 |
| Alimera Sciences, Inc. | 21 | $343 |
| Apellis Pharmaceuticals, Inc. | 18 | $262 |
| Astellas Pharma US Inc | 8 | $229 |
| AbbVie(2 entities) | 9 | $218 |
| Genentech USA, Inc. | 10 | $209 |
| Eyepoint US, Inc. | 5 | $108 |
| Novartis | 5 | $86 |
| Harrow Eye, LLC | 1 | $37 |
| Coherus Oncology, Inc. | 1 | $26 |
| Bausch & Lomb Americas Inc. | 1 | $24 |
| Sandoz | 1 | $24 |
| Biogen | 1 | $22 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
How this compares
$2,209 in reported general payments places this provider in the 35th percentile of 69 retina specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 63 | $3,699 |
| Ketorolac Tromethamine | 49 | $921 |
| Diclofenac Sodium | 44 | $531 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 31 | $342 |
| Tobramycin | 32 | $298 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $114 |
| Prednisone | 13 | $61 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Canton
- Baha Eddin El KhatibCanton$15K
- Arnold NothnagelCanton$5K
- Sophia PachydakiCanton$4K
- Mark GersmanCanton$3K
- Stephen ContiCanton$1K
- Richard WyszynskiCanton$920
- Deepam RusiaCanton$221
- Joseph ConeyBeachwood$980K
- Sumit SharmaCleveland$428K
- Aleksandra RachitskayaCleveland$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.